The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 5 01 ACQUISITION CORP | COM CL A | 33836P105 | 3,651 | 365,126 | SH | SOLE | 365,126 | 0 | 0 | ||
| AKOUOS INC | COM | 00973J101 | 27,958 | 4,135,784 | SH | SOLE | 4,135,784 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 17,796 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 6,378 | 390,555 | SH | SOLE | 390,555 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 712 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | ||
| CINCOR PHARMA INC | COM | 17240Y109 | 162,054 | 4,937,646 | SH | SOLE | 4,937,646 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 11,793 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 16,935 | 862,286 | SH | SOLE | 862,286 | 0 | 0 | ||
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | 69,476 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | ||
| GEMINI THERAPEUTICS INC | COM | 36870G105 | 860 | 524,500 | SH | SOLE | 524,500 | 0 | 0 | ||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 7,303 | 4,535,919 | SH | SOLE | 4,535,919 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 17,849 | 1,196,298 | SH | SOLE | 1,196,298 | 0 | 0 | ||
| IMPEL NEUROPHARMA INC | COM | 45258K109 | 14,049 | 2,884,791 | SH | SOLE | 2,884,791 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 9,129 | 508,847 | SH | SOLE | 508,847 | 0 | 0 | ||
| JANUX THERAPEUTICS INC | COM | 47103J105 | 6,042 | 446,266 | SH | SOLE | 446,266 | 0 | 0 | ||
| PEAR THERAPEUTICS INC | CLASS A COM | 704723105 | 34,483 | 16,903,603 | SH | SOLE | 16,903,603 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 4,507 | 587,600 | SH | SOLE | 587,600 | 0 | 0 | ||
| RALLYBIO CORP | COM | 75120L100 | 53,984 | 3,730,724 | SH | SOLE | 3,730,724 | 0 | 0 | ||
| SCPHARMACEUTICALS INC | COM | 810648105 | 21,743 | 3,334,852 | SH | SOLE | 3,334,852 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 9,945 | 484,891 | SH | SOLE | 484,891 | 0 | 0 | ||
| VOR BIOPHARMA INC | COM | 929033108 | 25,320 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | ||